Japan Drug Delivery Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The report covers Japan Drug Delivery Devices Companies and the market is segmented by route of administration (injectable, topical, ocular, and others), application, and by end user.

Japan Drug Delivery Devices Market Size

Market Snapshot1
View Global Report

Japan Drug Delivery Devices Market Analysis

The Japan Drug Delivery Devices Market is expected to register a CAGR of 4.5% during the forecast period.

Drug delivery devices help in delivering the drugs which are beneficial for the targeted population to recover faster. In addition, a rising number of cancers, respiratory are diabetic patients in Japan will promote the adoption of drug delivery devices and drive the overall market. For instance, according to the estimates of the National Cancer Center - Center for Cancer Control and Information Services, the cancer incidence in 2018 was 1,013,600 in Japan, while the most common types of cancer were colorectum, stomach, lung, breast, and prostate cancer. Thus, owing to the above-mentioned factors is expected to drive market growth over the forecast period.

Japan Drug Delivery Devices Industry Overview

The Japan Drug Delivery Devices Market is fragmented competitive and consists of several major players. Some of the companies which are currently dominating the market are Mylan N.V., ANTARES PHARMA, INC., Tasei Kako Co. Ltd., GlaxoSmithKline Plc, Novartis AG, Bayer AG, Becton, Dickinson and Company, Johnson & Johnson and 3M Company.

Japan Drug Delivery Devices Market Leaders

  1. Mylan N.V.

  2. ANTARES PHARMA, INC.

  3. Tasei Kako Co. Ltd.

  4. GlaxoSmithKline Plc

  5. Novartis AG

  6. *Disclaimer: Major Players sorted in no particular order
Japan landscape.png
Need More Details on Market Players and Competitors?
Download PDF

Japan Drug Delivery Devices Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence of Chronic Diseases
    • 4.2.2 Technological Advancements
  • 4.3 Market Restraints
    • 4.3.1 Risk of Needlestick Injuries
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 By Route of Administration
    • 5.1.1 Injectable
    • 5.1.2 Topical
    • 5.1.3 Ocular
    • 5.1.4 Other Route of Administration
  • 5.2 By Application
    • 5.2.1 Cancer
    • 5.2.2 Cardiovascular
    • 5.2.3 Diabetes
    • 5.2.4 Infectious diseases
    • 5.2.5 Other Applications
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Ambulatory Surgical Centers
    • 5.3.3 Other End Users

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Mylan N.V.
    • 6.1.2 Antares Pharma, Inc.
    • 6.1.3 Tasei Kako Co. Ltd.
    • 6.1.4 GlaxoSmithKline Plc
    • 6.1.5 Novartis AG
    • 6.1.6 Bayer AG
    • 6.1.7 Becton, Dickinson and Company
    • 6.1.8 Johnson & Johnson
    • 6.1.9 3M Company
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Japan Drug Delivery Devices Industry Segmentation

As per the scope, drug delivery devices or system are the tools which are used to deliver the drug through the specific route of administration. It enables the introduction of therapeutic substances in the body. The Japan Drug Delivery Devices Market is segmented by route of administration, application and end user.

By Route of Administration Injectable
Topical
Ocular
Other Route of Administration
By Application Cancer
Cardiovascular
Diabetes
Infectious diseases
Other Applications
By End User Hospitals
Ambulatory Surgical Centers
Other End Users
Need A Different Region or Segment?
Customize Now

Japan Drug Delivery Devices Market Research FAQs

What is the current Japan Drug Delivery Devices Market size?

The Japan Drug Delivery Devices Market is projected to register a CAGR of 4.5% during the forecast period (2025-2030)

Who are the key players in Japan Drug Delivery Devices Market?

Mylan N.V., ANTARES PHARMA, INC., Tasei Kako Co. Ltd., GlaxoSmithKline Plc and Novartis AG are the major companies operating in the Japan Drug Delivery Devices Market.

What years does this Japan Drug Delivery Devices Market cover?

The report covers the Japan Drug Delivery Devices Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Japan Drug Delivery Devices Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Japan Connected Drug Delivery Devices Industry Report

Statistics for the 2025 Japan Drug Delivery Devices market share, size and revenue growth rate, created by Mordor Intelligenceā„¢ Industry Reports. Japan Drug Delivery Devices analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.

Japan Connected Drug Delivery Devices Market Report Snapshots

Compare market size and growth of Japan Drug Delivery Devices Market with other markets in Healthcare Industry

Japan Drug Delivery Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)